Dr. Reddy’s Laboratories Ltd. today announced its consolidated financial results for the quarter and nine months ended December 31, 2023. The information mentioned in this release is based on.
Edity Therapeutics enters into a Strategic Collaboration with Dr Reddy s Laboratories to Advance Novel Cell Therapy Approach Using Edity s Proprietary Delivery Platform webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.
Dr. Reddy s Laboratories Ltd. , today announced that it has acquired MenoLabs® business, a leading women’s health and dietary supplement branded portfolio from Amyris, Inc. in Amyris’ Chapter.
03.01.2024 - Dr. Reddy s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as Dr. Reddy s ), today announced that it has acquired MenoLabs business, a leading women’s health and dietary . Seite 1
Dr Reddy s becomes first Indian pharma company to debut on the Dow Jones Sustainability World Index lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.